Phase II Study of Thalidomide (NSC 66847) in Patients With Sarcomas of Gynecologic Origin.
Phase of Trial: Phase II
Latest Information Update: 20 Jun 2013
At a glance
- Drugs Thalidomide (Primary)
- Indications Sarcoma
- Focus Adverse reactions; Therapeutic Use
- 22 Aug 2006 Status change
- 23 Sep 2005 New trial record.